![]() |
Brought to you by TCBY Yogurt
Monday, May 27, 2013
The Alabama Department of Public Health is working with other health agencies to investigate an injectable anti-inflammatory drug prepared by a compounding manufacturer in Tennessee.
Main Street Family Pharmacy of Newbern, Tenn. shipped the tainted medicine to clinics in 13 states, including to one clinic in Alabama.
The investigation began after the U.S. Food and Drug Administration was notified of seven people who developed infections or adverse reactions after receiving injections of methylprednisolone acetate (MPA). It's the same drug that was linked to last year's deadly outbreak of fungal meningitis.
The investigation is in an early stage and is rapidly evolving, according to Dr. Mary McIntyre of the ADPH.
The Alabama clinic will begin notifying patients to ask them to report any signs and symptoms of complications
Dental Health is Important for Children's 'Baby Teeth'
Lamb Chops and Red Wine: A Perfect Easter Pairing
Alabama Department of Public Health issues 2016 Fish Consumption
Aquarium animals and plants should never be released in the wild
Keywords: The Alabama Department of Public Health ,injectable anti-inflammatory drug ,tainted medicine ,U.S. Food and Drug Administration,
Visit Local News
There currently are no approved comments for this blog article. To join the discussion click here.